Is lobular endocervical glandular hyperplasia a cancerous precursor of minimal deviation adenocarcinoma?: A comparative molecular-genetic and immunohistochemical study

American Journal of Surgical Pathology

Volumn 32, Issue 12, 2008, Pages 1807-1815

  Kawauchi, Shigeto ^a   Kusuda, Tomoko ^a   Liu, Xu Ping ^a   Suehiro, Yutaka ^a   Kaku, Tsunehisa ^b   Mikami, Yoshiki ^c   Takeshita, Morishige ^d   Nakao, Motonao ^a   Chochi, Yasuyo ^a   Sasaki, Kohsuke ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY HOSPITAL   (Japan)

^d FUKUOKA UNIVERSITY   (Japan)

Author keywords

Chromosomal imbalance; Comparative genomic hybridization; Gastric pyloric type mucin; Human papillomavirus; Lobular endocervical glandular hyperplasia; Microsatellite instability; Minimal deviation adenocarcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CHROMOSOME 1P; CHROMOSOME 3Q; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOBULAR ENDOCERVICAL GLANDULAR HYPERPLASIA; MICROSATELLITE INSTABILITY; STOMACH SECRETION; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS; ADENOCARCINOMA; GENETICS; HYPERPLASIA; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; PRECANCER; UTERINE CERVIX; UTERINE CERVIX TUMOR; VIROLOGY;

ADENOCARCINOMA; ADULT; AGED; CERVIX UTERI; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MICROSATELLITE INSTABILITY; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; UTERINE CERVICAL NEOPLASMS;

EID: 58749098432     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181883722     Document Type: Article

References (37)

1. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58:5248-5257.
2. Ferguson AW, Svoboda-Newman SM, Frank TS. Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix. Mod Pathol. 1998;11:11-18.
3. Gilks CB, Young RH, Aguirre P, et al. Adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix: a clinicopathological and immunohistochemical analysis of 26 cases. Am J Surg Pathol. 1989;13:717-729.
4. Guan XY, Sham JS, Tang TC, et al. Isolation of a novel candidate oncogene within a frequently amplified region at 3q26 in ovarian cancer. Cancer Res. 2001;61:3806-3809.
5. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000; 100:57-70.
6. Heselmeyer K, Schrock E, du Manoir SD, et al. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA. 1996;93:479-484.
7. Hirai Y, Utsugi K, Takeshima N, et al. Putative gene loci associated with carcinogenesis and metastasis of endocervical adenocarcinomas of uterus determined by conventional and array-based CGH. Am J Obstet Gynecol. 2004;191:1173-1182.
8. Hirose Y, Aldape K, Takahashi M, et al. Tissue microdissection and degenerate oligonucleotide primed-polymerase chain reaction (DOP-PCR) is an effective method to analyze genetic aberrations in invasive tumors. J Mol Diagn. 2001;3:62-67.
9. Ishii K, Hosaka N, Toki T, et al. A new view of the so-called adenoma malignum of the uterine cervix. Virchows Arch. 1998;432: 315-322.
10. Kallioniemi A, Kallioniemi OP, Sudar D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science. 1992;258:818-821.
11. Kawauchi S, Liu XP, Kawasaki K, et al. Significance of β-catenin and pRB pathway components in malignant ovarian germ cell tumours: INK4A promoter CpG island methylation is associated with cell proliferation. J Pathol. 2004;204:268-276.
12. Kawauchi S, Okuda S, Morioka H, et al. Large cell neuroendocrine carcinoma of the uterine cervix with cytogenetic analysis by comparative genomic hybridization: a case study. Hum Pathol. 2005;36:1096-1100.
13. Kitayama Y, Igarashi H, Sugimura H. Initial intermittent microwave irradiation for fluorescence in situ hybridization analysis in paraffin-embedded tissue sections of gastrointestinal neoplasia. Lab Invest. 2000;80:779-781.
14. Kondo T, Hashi A, Murata S, et al. Endocervical adenocarcinomas associated with lobular endocervical glandular hyperplasia: a report of four cases with histochemical and immunohistochemical analyses. Mod Pathol. 2005;18:1199-1210.
15. Kondo Y, Shen L, Issa JP. Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer. Mol Cell Biol. 2003;23:206-215.
16. Kurman RJ, Norris HJ, Wilkinson E. Tumors of the cervix. In: Rosai J, Sobin LH, eds. Atlas of Tumor Pathology, Tumors of the Cervix, Vagina and Vulva. 3rd Series. Washington, DC: AFIP; 1992:91-93.
17. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in colorectal cancers. Nature. 1997;386:623-627.
18. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature. 1998;396:643-649.
19. Ma YY, Wei SJ, Lin YC, et al. PIK3CA as an oncogene in cervical cancer. Oncogene. 2000;19:2739-2744.
20. Mikami Y, Hata S, Melamed J, et al. Lobular endocervical glandular hyperplasia is a metaplastic process with a pyloric gland phenotype. Histopathology. 2001;39:364-372.
21. Mikami Y, Kiyokawa T, Hata S, et al. Gastrointestinal immuno-phenotype in adenocarcinomas of the uterine cervix and related glandular lesions: a possible link between lobular endocervical glandular hyperplasia/pyloric gland metaplasia and 'adenoma malignum.' Mod Pathol. 2004;17:962-972.
22. Nucci MR, Clement PB, Young RH. Lobular endocervical glandular hyperplasia, not otherwise specified: a clinicopathologic analysis of thirteen cases of a distinctive pseudoneoplastic lesion and comparison with fourteen cases of adenoma malignum. Am J Surg Pathol 1999;23:886-891.
23. Peng DF, Sugihara H, Mukaisho K, et al. Genetic lineage of poorly differentiated gastric carcinoma with a tubular component analyzed by comparative genomic hybridization. J Pathol. 2004;203:884-895.
24. Pisani P, Bray F, Parkin DM. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer. 2002;97:72-81.
25. Prolla TA, Pang Q, Alani E, et al. MLH1, PMS1, and MSH2 interactions during the initiation of mismatch repair in yeast. Science. 1994;265:1091-1093.
26. Qian J, Bostwick DG, Takahashi S, et al. Comparison of fluorescence in situ hybridization analysis of isolated nuclei and routine histological sections from paraffin-embedded prostatic adenocarcinoma specimens. Am J Pathol. 1996;149: 1193-1199.
27. Redon R, Hussenet T, Bour G, et al. Amplicon mapping and transcriptional analysis pinpoint cyclin L as a candidate oncogene in head and neck cancer. Cancer Res. 2002;62:6211-6217.
28. Smith HO, Tiffany MF, Qualls CR, et al. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States: a 24-year population based study. Gynecol Oncol. 2000;78:97-105.
29. Wells M, Nesland JM, Oster AG, et al. Tumours of the uterine cervix. In: Tavassoli FA, Devilee P, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC Press; 2003: 272-277.
30. Wilting SM, Snijders PJ, Meijer GA, et al. Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix. J Pathol. 2006;209: 220-230.
31. Wolman SR. Karyotypic progression of human tumors. Cancer Metast Rev. 1983;2:257-293.
32. Xu JY, Hashi A, Kondo T, et al. Absence of human papillomavirus infection in minimal deviation adenocarcinoma and lobular endocervical glandular hyperplasia. Int J Gynecol Pathol. 2005;24: 296-302.
33. Yang P, Hirose T, Hasegawa T, et al. Dual-color fluorescence in situ hybridization analysis of synovial sarcoma. J Pathol. 1998;184:7-13.
34. Yang YC, Shyong WY, Chang MS, et al. Frequent gain of copy number on the long arm of chromosome 3 in human cervical adenocarcinoma. Cancer Genet Cytogenet. 2001;131:48-53.
35. Young RH, Clement PB. Endocervical adenocarcinoma and its variants: their morphology and differential diagnosis. Histopathology. 2002;41:185-207.
36. Zappa M, Visioli CB, Ciatto S, et al. Lower protection of cytological screening for adenocarcinomas and shorter protection for younger women: the results of a case-control study in Florence. Br J Cancer. 2004;90:1784-1786.
37. Zielinski GD, Snijders PJ, Rozendaal L, et al. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix. J Pathol. 2003;201:535-543.